Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Santander
Clinical trial register · Spain

Clinical Trials in Santander, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 56 Madrid 54 Valencia 21 Málaga 19 Santander 14
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona56 Madrid54 Valencia21 Málaga19 Santander14
All 70 locations
Target enrolment
to

Trials with a site in Santander

14 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
GlaxoSmithKline
Phase 3
420
Barcelona, L'Hospitalet de Llobrega, Las Palmas de Gran Canar, Madrid, Santander
2025-08-11
Recruiting
GlaxoSmithKline
Phase 1/2
451
Barcelona, HebrOn, Madrid, Pamplona, Santander, Zaragoza
2025-06-11
Active, closed
GlaxoSmithKline
Phase 2
307
Alcorcon Madrid, Barcelona, Benalmádena, Jerez de la Frontera, Madrid, Málaga, Santander, Seville
2025-02-10
Active, closed
GlaxoSmithKline
Phase 2
283
Barcelona, León, Madrid, Salamanca, Santander, Valencia
2024-11-11
Recruiting
GlaxoSmithKline
Phase 2
393
Barcelona, León, Madrid, Santander, Seville, Valencia, Valladolid, Vigo
2024-09-27
Recruiting
GlaxoSmithKline
Phase 3
440
Pamplona Iruna, Barcelona, Córdoba, Granada, Madrid, Málaga, Santander, Seville
2024-09-11
Recruiting
GlaxoSmithKline
Phase 3
150
Barcelona, Benalmádena, Madrid, Palma de Mallorca, Santander
2024-07-19
Active, closed
GlaxoSmithKline
Phase 2
316
Barcelona, Jaén, Madrid, Pozuelo de AlarcOn Madr, Salamanca, Santander, Valencia, Zaragoza
2023-11-14
Active, closed
GlaxoSmithKline
Phase 2
154
Barcelona, Granada, Madrid, Santander, Valencia
2023-04-03
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
GlaxoSmithKline
Phase 2
284
Barcelona, Madrid, Málaga, Sabadell Barcelona, Santander, Seville, Vigo
2023-01-02
Active, closed
GlaxoSmithKline
Phase 2
360
HebrOn, León, Madrid, Santander, Valencia, Vigo
2021-12-14
Active, closed
GlaxoSmithKline
Phase 1
118
Badalona, Barcelona, Madrid, Málaga, PamplonaNavarra, Pozuelo de AlarcOn Madr, Santander
2019-12-18
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/santander

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Santander that also match the filters currently applied.

How many clinical trials are recruiting in Santander?

6 of the 14 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Santander), 14 studies
PhaseStudiesRecruitingShare
Phase 28157.1%
Phase 34428.6%
Phase 1107.1%
Phase 1/2117.1%

Most active sponsors

Lead sponsors with the most studies (Santander)
Lead sponsorStudiesRecruiting
GlaxoSmithKline146
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.